Jiang Du

698 total citations
31 papers, 547 citations indexed

About

Jiang Du is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Jiang Du has authored 31 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Physiology. Recurrent topics in Jiang Du's work include Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Lysosomal Storage Disorders Research (3 papers). Jiang Du is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Lysosomal Storage Disorders Research (3 papers). Jiang Du collaborates with scholars based in China, United States and Malaysia. Jiang Du's co-authors include Juntang Lin, Xinxing Zhu, Yanli Liu, Liang Qiao, Rui Guo, Genshen Zhong, Jinjin Yu, Lihong Guan, Yanyan Feng and Xinyue Song and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Jiang Du

28 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiang Du China 15 288 107 81 71 65 31 547
Lei Lei China 19 619 2.1× 110 1.0× 45 0.6× 54 0.8× 90 1.4× 63 989
Haruka Hirose Japan 12 305 1.1× 147 1.4× 60 0.7× 45 0.6× 39 0.6× 35 579
Eric Van Buren United States 15 370 1.3× 115 1.1× 62 0.8× 55 0.8× 57 0.9× 33 809
Yunkai Yang China 5 403 1.4× 132 1.2× 45 0.6× 52 0.7× 82 1.3× 8 735
Detian Yuan China 14 549 1.9× 135 1.3× 84 1.0× 95 1.3× 87 1.3× 19 859
Robert J. Corona United States 11 297 1.0× 105 1.0× 34 0.4× 77 1.1× 33 0.5× 21 646
Stephan Hoffmann Germany 13 408 1.4× 83 0.8× 58 0.7× 38 0.5× 53 0.8× 20 725
Pedro Cruz United States 13 365 1.3× 87 0.8× 53 0.7× 21 0.3× 65 1.0× 19 589

Countries citing papers authored by Jiang Du

Since Specialization
Citations

This map shows the geographic impact of Jiang Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang Du more than expected).

Fields of papers citing papers by Jiang Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang Du. The network helps show where Jiang Du may publish in the future.

Co-authorship network of co-authors of Jiang Du

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang Du. A scholar is included among the top collaborators of Jiang Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang Du. Jiang Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Jiang, et al.. (2025). RNF186 controls glucose metabolism in metabolic dysfunction-associated fatty liver disease. Cell & Bioscience. 15(1). 164–164.
2.
Du, Jiang, Yujie Li, Yuxuan Zhang, et al.. (2025). METTL1-mediated m7G methylation of FoxO1 regulates lipid metabolism in metabolic dysfunction-associated fatty liver disease. Metabolism. 174. 156420–156420.
3.
Jiang, Yan, et al.. (2024). Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease. World Journal of Stem Cells. 16(7). 760–772. 5 indexed citations
4.
Du, Jiang, Xiang Ji, Bo Xu, et al.. (2023). Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease. Metabolism. 152. 155769–155769. 11 indexed citations
5.
Zhang, Yan, et al.. (2022). Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPARα/Fgf21 signaling. Molecular Biology Reports. 49(4). 3113–3122. 13 indexed citations
6.
Yang, Minlin, Liang Qiao, Han Li, et al.. (2022). CRISPR-Cas9-Mediated NPC1 Gene Deletion Enhances HEK 293 T Cell Adhesion by Regulating E-Cadherin. Molecular Biotechnology. 65(2). 252–262. 5 indexed citations
7.
Guan, Lihong, et al.. (2021). CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders. Molecular Neurobiology. 59(2). 968–982. 38 indexed citations
8.
Li, Yonghai, Junzheng Yang, Meng Li, et al.. (2020). The Extracts of Human Fetal Brain Induce the Differentiation of Human Umbilical Cord Mesenchymal Stem Cells into Dopaminergic Neuron Containing Cells. Cellular Reprogramming. 22(5). 254–261. 1 indexed citations
9.
Liu, Yanli, Fen Yang, Yuliang Sun, et al.. (2020). Biological characteristics of endometriotic mesenchymal stem cells isolated from ectopic lesions of patients with endometriosis. Stem Cell Research & Therapy. 11(1). 346–346. 26 indexed citations
10.
Du, Jiang, et al.. (2020). Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury. Stem Cell Research & Therapy. 11(1). 192–192. 35 indexed citations
11.
Guo, Rui, Yun Yang, Di Zhang, et al.. (2020). A bispecific immunotoxin (IHPP) with a long half-life targeting HER2 and PDGFRβ exhibited improved efficacy against HER2-positive tumors in a mouse xenograft model. International Journal of Pharmaceutics. 592. 120037–120037. 8 indexed citations
12.
He, Yanan, Yuliang Sun, Liang Qiao, et al.. (2019). The T cell activating properties and antitumour activity of Staphylococcal Enterotoxin-like Q. Medical Microbiology and Immunology. 208(6). 781–792. 3 indexed citations
13.
Li, Wenqiang, Xiaoshan Fan, Jiang Du, et al.. (2018). Reduction-responsive shell cross-linked micelles derived from amphiphilic triblock copolymer as anticancer drug delivery carrier. Materials Science and Engineering C. 96. 383–390. 23 indexed citations
14.
Zhong, Yadong, et al.. (2018). Improved Tol2-mediated enhancer trap identifies weakly expressed genes during liver and β cell development and regeneration in zebrafish. Journal of Biological Chemistry. 294(3). 932–940. 6 indexed citations
15.
Nan, Wenbin, Xiaoyue Zhang, Yuliang Sun, et al.. (2018). Umbilical Cord Mesenchymal Stem Cells Conditioned Medium Promotes Aβ25-35 phagocytosis by Modulating Autophagy and Aβ-Degrading Enzymes in BV2 Cells. Journal of Molecular Neuroscience. 65(2). 222–233. 17 indexed citations
16.
Zhu, Xinxing, Yanli Liu, Jinjin Yu, et al.. (2018). LncRNA HOXA-AS2 represses endothelium inflammation by regulating the activity of NF-κB signaling. Atherosclerosis. 281. 38–46. 33 indexed citations
17.
Zhu, Xinxing, Jiang Du, Jinjin Yu, et al.. (2018). LncRNA NKILA regulates endothelium inflammation by controlling a NF-κB/KLF4 positive feedback loop. Journal of Molecular and Cellular Cardiology. 126. 60–69. 51 indexed citations
18.
Du, Jiang, Qifen Yang, Lingfei Luo, & Deqin Yang. (2016). C1qr and C1qrl redundantly regulate angiogenesis in zebrafish through controlling endothelial Cdh5. Biochemical and Biophysical Research Communications. 483(1). 482–487. 14 indexed citations
19.
Du, Jiang, et al.. (2012). Mitochondrial bioenergetic deficits in the hippocampi of rats with chronic ischemia-induced vascular dementia. Neuroscience. 231. 345–352. 59 indexed citations
20.
Du, Jiang, Xin Cai, Xuebiao Yao, et al.. (2008). The mitotic checkpoint kinase NEK2A regulates kinetochore microtubule attachment stability. Oncogene. 27(29). 4107–4114. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026